Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 44% ± 22% | |
lung | 11 studies | 23% ± 8% | |
eye | 8 studies | 31% ± 18% | |
peripheral blood | 6 studies | 21% ± 4% | |
liver | 5 studies | 30% ± 14% | |
heart | 4 studies | 34% ± 8% | |
adipose | 4 studies | 30% ± 9% | |
intestine | 3 studies | 22% ± 6% | |
kidney | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6769.93 | 1445 / 1445 | 100% | 16.02 | 183 / 183 |
pancreas | 100% | 3551.25 | 328 / 328 | 99% | 11.85 | 176 / 178 |
breast | 100% | 5561.51 | 459 / 459 | 99% | 19.81 | 1104 / 1118 |
lung | 100% | 7219.61 | 578 / 578 | 98% | 12.78 | 1136 / 1155 |
brain | 100% | 7589.12 | 2641 / 2642 | 98% | 18.36 | 693 / 705 |
prostate | 100% | 7038.91 | 245 / 245 | 98% | 16.47 | 491 / 502 |
stomach | 100% | 5242.76 | 359 / 359 | 97% | 10.78 | 277 / 286 |
bladder | 100% | 6904.05 | 21 / 21 | 97% | 10.87 | 487 / 504 |
thymus | 100% | 5607.93 | 653 / 653 | 96% | 13.03 | 582 / 605 |
intestine | 100% | 6937.43 | 966 / 966 | 96% | 10.17 | 505 / 527 |
uterus | 100% | 6986.91 | 170 / 170 | 95% | 10.32 | 435 / 459 |
skin | 100% | 6305.53 | 1809 / 1809 | 93% | 14.51 | 441 / 472 |
kidney | 100% | 3649.09 | 89 / 89 | 93% | 10.38 | 840 / 901 |
liver | 100% | 3916.69 | 226 / 226 | 88% | 8.20 | 357 / 406 |
adrenal gland | 100% | 5506.65 | 258 / 258 | 86% | 8.74 | 197 / 230 |
ovary | 100% | 6086.74 | 180 / 180 | 75% | 4.73 | 324 / 430 |
blood vessel | 100% | 8565.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 12266.85 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4827.23 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.19 | 1 / 1 |
adipose | 100% | 5489.56 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 7663.02 | 843 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.00 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 9.15 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 73% | 5.93 | 58 / 80 |
peripheral blood | 60% | 2045.91 | 557 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043154 | Biological process | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0034644 | Biological process | cellular response to UV |
GO_0006974 | Biological process | DNA damage response |
GO_0035520 | Biological process | monoubiquitinated protein deubiquitination |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0006508 | Biological process | proteolysis |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_1902230 | Biological process | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0016579 | Biological process | protein deubiquitination |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0006284 | Biological process | base-excision repair |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0005634 | Cellular component | nucleus |
GO_0101005 | Molecular function | deubiquitinase activity |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0071987 | Molecular function | WD40-repeat domain binding |
GO_0005515 | Molecular function | protein binding |
Gene name | USP47 |
Protein name | USP47 protein Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) |
Synonyms | |
Description | FUNCTION: Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level. . |
Accessions | ENST00000339865.9 [Q96K76-2] ENST00000399455.2 [Q96K76-1] Q96K76 A0PJ80 ENST00000527733.7 [Q96K76-4] |